questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Ischémie myocardique
Maladie coronarienne
Sténose coronarienne
Resténose coronaire
Resténose coronaire : Questions médicales fréquentes
Diagnostic
5
Resténose coronaire
Angiographie
Tests d'effort
Échographie intravasculaire
Angiographie
Resténose coronaire
Douleur thoracique
Essoufflement
Resténose coronaire
Scintigraphie cardiaque
Perfusion myocardique
Resténose coronaire
Angioplastie
Ischémie
Resténose coronaire
Symptômes
5
Douleur thoracique
Fatigue
Essoufflement
Asymptomatique
Resténose coronaire
Symptômes
Douleur thoracique
Sensation de serrement
Resténose coronaire
Symptômes
Variabilité
Resténose coronaire
Consultation médicale
Douleur thoracique
Resténose coronaire
Prévention
5
Prévention
Mode de vie sain
Facteurs de risque
Cholestérol
Prévention
Resténose coronaire
Exercice
Santé cardiaque
Prévention
Contrôles médicaux
Santé cardiaque
Prévention
Stress
Santé cardiaque
Resténose coronaire
Traitements
5
Revascularisation
Médicaments
Resténose coronaire
Stents
Stents médicamenteux
Resténose coronaire
Médicaments antiagrégants
Caillots
Resténose coronaire
Chirurgie de pontage
Resténose coronaire
Traitements
Surveillance
Tests d'effort
Resténose coronaire
Complications
5
Angine de poitrine
Infarctus du myocarde
Complications
Infarctus du myocarde
Resténose coronaire
Risque
Qualité de vie
Activité physique
Resténose coronaire
Complications
Gestion
Resténose coronaire
Douleurs thoraciques
Complications
Urgence médicale
Facteurs de risque
5
Tabagisme
Hypertension
Diabète
Âge
Risque
Resténose coronaire
Diabète
Risque
Resténose coronaire
Mode de vie sédentaire
Risque
Resténose coronaire
Stress
Hypertension
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Resténose coronaire : Questions médicales les plus fréquentes",
"headline": "Resténose coronaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Resténose coronaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Resténose coronaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sténose coronarienne",
"url": "https://questionsmedicales.fr/mesh/D023921",
"about": {
"@type": "MedicalCondition",
"name": "Sténose coronarienne",
"code": {
"@type": "MedicalCode",
"code": "D023921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.585.250.285"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Resténose coronaire",
"alternateName": "Coronary Restenosis",
"code": {
"@type": "MedicalCode",
"code": "D023903",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tommaso Gori",
"url": "https://questionsmedicales.fr/author/Tommaso%20Gori",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moa Pehrson",
"url": "https://questionsmedicales.fr/author/Moa%20Pehrson",
"affiliation": {
"@type": "Organization",
"name": "Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden."
}
},
{
"@type": "Person",
"name": "Giovanna Sarno",
"url": "https://questionsmedicales.fr/author/Giovanna%20Sarno",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden."
}
},
{
"@type": "Person",
"name": "Abigail Fraser",
"url": "https://questionsmedicales.fr/author/Abigail%20Fraser",
"affiliation": {
"@type": "Organization",
"name": "Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom."
}
},
{
"@type": "Person",
"name": "Janet W Rich-Edwards",
"url": "https://questionsmedicales.fr/author/Janet%20W%20Rich-Edwards",
"affiliation": {
"@type": "Organization",
"name": "Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Coronary Artery Restenosis in Women by History of Preeclampsia.",
"datePublished": "2022-09-08",
"url": "https://questionsmedicales.fr/article/36073639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/JAHA.122.026287"
}
},
{
"@type": "ScholarlyArticle",
"name": "Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ccd.30399"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.",
"datePublished": "2023-08-07",
"url": "https://questionsmedicales.fr/article/37283548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4244/EIJ-D-23-00107"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of serum apoA-I with in-stent restenosis in coronary heart disease.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/35927634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12872-022-02762-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence, Management and Outcomes of Percutaneous Coronary Intervention for Coronary In-Stent Restenosis: Insights From the France PCI Registry.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36813696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.carrev.2023.02.006"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ischémie myocardique",
"item": "https://questionsmedicales.fr/mesh/D017202"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladie coronarienne",
"item": "https://questionsmedicales.fr/mesh/D003327"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sténose coronarienne",
"item": "https://questionsmedicales.fr/mesh/D023921"
},
{
"@type": "ListItem",
"position": 7,
"name": "Resténose coronaire",
"item": "https://questionsmedicales.fr/mesh/D023903"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Resténose coronaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Resténose coronaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Resténose coronaire",
"description": "Comment diagnostique-t-on la resténose coronaire ?\nQuels examens sont utilisés pour évaluer la resténose ?\nQuels symptômes peuvent indiquer une resténose ?\nLa scintigraphie cardiaque est-elle utile ?\nQuand faut-il suspecter une resténose après une angioplastie ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Resténose coronaire",
"description": "Quels sont les symptômes courants de la resténose ?\nLa resténose peut-elle être asymptomatique ?\nComment la douleur thoracique se manifeste-t-elle ?\nLes symptômes varient-ils selon les patients ?\nQuand consulter un médecin pour des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Resténose coronaire",
"description": "Comment prévenir la resténose coronaire ?\nLe contrôle du cholestérol aide-t-il à prévenir la resténose ?\nL'exercice régulier est-il bénéfique ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLe stress peut-il influencer la resténose ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Resténose coronaire",
"description": "Quels traitements sont disponibles pour la resténose ?\nLes stents sont-ils efficaces contre la resténose ?\nQuel rôle jouent les médicaments antiagrégants ?\nLa chirurgie est-elle une option pour la resténose ?\nComment la surveillance post-interventionnelle est-elle effectuée ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Resténose coronaire",
"description": "Quelles complications peuvent survenir avec la resténose ?\nLa resténose augmente-t-elle le risque d'infarctus ?\nComment la resténose affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Resténose coronaire",
"description": "Quels sont les principaux facteurs de risque de resténose ?\nL'âge influence-t-il le risque de resténose ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress peut-il aggraver les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D023903#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la resténose coronaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est diagnostiquée par angiographie coronarienne et tests d'effort."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la resténose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie et l'échographie intravasculaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une resténose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques ou un essoufflement peuvent signaler une resténose."
}
},
{
"@type": "Question",
"name": "La scintigraphie cardiaque est-elle utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à détecter des zones de mauvaise perfusion myocardique."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une resténose après une angioplastie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si le patient présente des symptômes d'ischémie dans les mois suivant l'intervention."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la resténose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, fatigue et essoufflement à l'effort."
}
},
{
"@type": "Question",
"name": "La resténose peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients ne présentent aucun symptôme malgré la resténose."
}
},
{
"@type": "Question",
"name": "Comment la douleur thoracique se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être ressentie comme une pression ou une sensation de serrement dans la poitrine."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'un patient à l'autre."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter immédiatement en cas de douleur thoracique persistante."
}
},
{
"@type": "Question",
"name": "Comment prévenir la resténose coronaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, l'arrêt du tabac et la gestion des facteurs de risque sont essentiels."
}
},
{
"@type": "Question",
"name": "Le contrôle du cholestérol aide-t-il à prévenir la resténose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un taux de cholestérol sain réduit le risque de resténose."
}
},
{
"@type": "Question",
"name": "L'exercice régulier est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la santé cardiaque et peut prévenir la resténose."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de surveiller la santé cardiaque et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la resténose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les problèmes cardiaques et favoriser la resténose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la resténose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la revascularisation, les médicaments et la surveillance."
}
},
{
"@type": "Question",
"name": "Les stents sont-ils efficaces contre la resténose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les stents, surtout les stents médicamenteux, réduisent le risque de resténose."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les médicaments antiagrégants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à prévenir la formation de caillots et à réduire le risque de resténose."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la resténose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas, une chirurgie de pontage peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Comment la surveillance post-interventionnelle est-elle effectuée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle implique des contrôles réguliers et des tests d'effort pour évaluer la fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la resténose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'angine de poitrine, l'infarctus du myocarde et l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "La resténose augmente-t-elle le risque d'infarctus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la resténose peut augmenter le risque d'infarctus du myocarde."
}
},
{
"@type": "Question",
"name": "Comment la resténose affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut limiter l'activité physique et entraîner des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques sévères, des sueurs ou des nausées doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de resténose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de resténose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de resténose augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente significativement le risque de resténose."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire contribue à l'augmentation du risque de resténose."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber d'autres facteurs de risque comme l'hypertension."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Department of Obstetrics and Gynecology Skåne University Hospital Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: samin.sharma@mountsinai.org.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
School of Medicine, The University of Western Australia, Perth, WA 6009, Australia.
Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Del. Tlalpan, 14080, Mexico City, Mexico. gvargas63@yahoo.com.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: ron.waksman@medstar.net.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Unit of Interventional Cardiology, Mediterranea Cardiocentro, Naples, Italy.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Carle Heart & Vascular Institute, Carle Illinois College of Medicine, University of Illinois UC, Champaign, Illinois. Electronic address: imoussa@illinois.edu.
Publications dans "Resténose coronaire" :
Background A history of preeclampsia is associated with increased risk of coronary artery disease and experimental evidence suggests that a history of preeclampsia also increases the risk of restenosi...
One strategy to improve the effectiveness of intravascular brachytherapy (IVBT) is to study its failures. Previous investigations described mostly discrete, focal recurrences, typically at the proxima...
Records of 53 unselected IVBT patients treated between 2016 and 2021 were reviewed. Thirty of the 53 patients had at least one subsequent percutaneous intervention (PCI) for in-stent restenosis (ISR) ...
Of the 30 patients, 21 (70%) developed recurrent ISR within the irradiated segment. Six of the 21 patients who failed within the irradiated segment also experienced ISR proximal or distal to the irrad...
We have shown here that 50% of failures after coronary IVBT for DES ISR occur exclusively within the irradiated segment. An additional 20% of patients had failure within and outside of the irradiated ...
Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood....
We aimed to clarify the cause of ostial RCA ISR using intravascular ultrasound (IVUS)....
Overall, 139 ostial RCA ISR lesions were identified with IVUS, pre-revascularisation. Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoatherosclerosis; 3) osti...
The median duration from prior stenting was 1.2 (first quartile 0.6, third quartile 3.1) years. The primary mechanisms of ISR were NIH in 25% (n=35) of lesions, neoatherosclerosis in 22% (n=30), uncov...
Half of the ostial RCA ISRs were due to mechanical causes. Subsequent event rates were high, especially in mechanically caused ISRs treated without the implantation of a new stent....
Despite use of drug-eluting stents (DES), in-stent restenosis (ISR) continues adversely affecting clinical outcomes of patients undergoing percutaneous coronary intervention (PCI). Apolipoprotein A-I ...
In this retrospective case control study, 604 consecutive patients who underwent DES implantation before were enrolled. Patients who underwent repeat angiography within 12 months were included in the ...
In the early ISR study, 8.8% (18 of 205) patients developed ISR. Serum apoA-I in the ISR group was lower than that in the non-ISR group (1.1 ± 0.26 vs. 1.24 ± 0.23, P < 0.05). On multivariate logistic...
ApoA-I was an independent risk factor for ISR, and showed a negative correlation with ISR after DES-based PCI. Combined use of apoA-I and clinical indicators may better predict the incidence of ISR un...
Despite the evolution of stent technology, there is a non-negligible risk of in-stent restenosis (ISR) after Percutaneous coronary intervention (PCI). Large-scale registry data on the prevalence and c...
The aim was to describe the epidemiology and management of patients with ≥1 ISR lesions treated with PCI (ISR PCI). Data on characteristics, management and clinical outcomes were analyzed for patients...
Between January 2014 and December 2018, 31,892 lesions were treated in 22,592 patients, 7.3 % of whom underwent ISR PCI. Patients undergoing ISR PCI were older (68.5 vs 67.8; p < 0.001), and more like...
In a large all-comers registry, ISR PCI was not infrequent and associated with worse prognosis than non-ISR PCI. Further studies and technical improvements are warranted to improve the outcomes of ISR...
Coronary artery disease (CAD) is a major cause of death worldwide. Revascularization via stent placement or coronary artery bypass grafting (CABG) are standard treatments for CAD. Despite a high succe...
Five thousand two hundred and forty-two patients were enrolled in this study and were assigned as follows: Stenosis Group: 3570 patients with CAD >50% without a prior stent or CABG (1394 genotyped), a...
Dyslipidemia is a major risk factor (Odds Ratio (OR) = 2.14, P-value <0.0001) for restenosis particularly among men (OR = 2.32, P < 0.0001), while type 2 diabetes (T2D) was associated with an increase...
The rs9349379 in...
Calcified nodule (CN) has been known as the advanced stage of coronary calcification. However, clinical outcomes following percutaneous coronary intervention (PCI) to CN remain unknown. This study aim...
Two hundred forty-nine lesions undergoing intravascular ultrasound-guided PCI with rotational atherectomy (RA) were enrolled and divided into the CN group (n=100) and the non-CN group (n=149) accordin...
The incidence of CD-TLR was significantly higher in the CN group than in the non-CN group. In the landmark analysis at 1 year, the CN group showed a significantly higher incidence of CD-TLR within 1 y...
In the heavily calcified lesions requiring RA, CN was the factor associated with the higher rate of CD-TLR especially within 1 year. The timing of CD-TLR in lesions with CN may indicate that the proce...
Despite ongoing progress in stent technology and deployment techniques, in-stent restenosis (ISR) still remains a major issue following percutaneous coronary intervention (PCI) and accounts for 10.6% ...
The triglyceride-glucose (TyG) index, a reliable surrogate indicator of insulin resistance, is independently associated with coronary artery disease of various clinical manifestations. This study aime...
A total of 1414 participants were enrolled and divided into groups according to the tertiles of the TyG index. The primary endpoint was a composite of PCI complications, including repeat revasculariza...
Over a median follow-up of 60 months, 548 (38.76%) patients had experienced at least one primary endpoint event. The follow-up incidence of the primary endpoint increased with the TyG index tertiles. ...
An increased TyG index was associated with elevated risk for long-term PCI complications, including repeat revascularization and ISR. Our study suggested that the TyG index could be a potent predictor...
Percutaneous coronary intervention (PCI) combined with stent implantation is currently one of the most effective treatments for coronary artery disease (CAD). However, in-stent restenosis (ISR) signif...